Cohen, Sasson

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cohen, Sasson.The latest application filed is for "immediate release formulation of n-(2-propylpentanoyl)glycinamide".

Company Profile

0.8.5

Cohen, Sasson - Tel Aviv IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Sustained release formulation of N- (2-propylpentanoyl) glycinamide and related compounds App 20040175423 - Licht, Daniella ; et al.	2004-09-09
Immediate release formulation of n-(2-propylpentanoyl)glycinamide App 20040176463 - Licht, Daniella ; et al.	2004-09-09
Compositions containing and methods of using N-acyl-1H-aminoindenes Grant 6,737,547 - Sklarz , et al. May 18, 2	2004-05-18
Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in an immediate-release layer with levodopa ethyl ester in a controlled release core App 20030152628 - Licht, Daniela ; et al.	2003-08-14
Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release core App 20030147957 - Licht, Daniela ; et al.	2003-08-07
Compositions Containing And Methods Of Using 1-aminoindan And Derivatives Thereof And Process For Preparing Optically Active 1-aminoindan Derivatives App 20020068839 - COHEN, SASSON ; et al.	2002-06-06
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives Grant 5,994,408 - Cohen , et al. November 30, 1	1999-11-30
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives Grant 5,914,349 - Cohen , et al. June 22, 1	1999-06-22
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives Grant 5,877,221 - Cohen , et al. March 2, 1	1999-03-02
Pharmaceutical composition of L-DOPA ester Grant 5,840,756 - Cohen , et al. November 24, 1	1998-11-24
Composition for topical treatment of psoriasis and atopic dermatitis comprising a xanthine derivative Grant 5,565,462 - Eitan , et al. October 15, 1	1996-10-15
Spiro (1,3-dioxolane-4,3') quinuclidine compounds Grant 4,104,397 - Cohen , et al. August 1, 1	1978-08-01
6-Oxa-1-aza tricyclo dodecan-5-ones as psychomotor stimulators Grant 4,083,985 - Cohen , et al. April 11, 1	1978-04-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.